Teva Pharmaceutical Industries Ltd (TEVA) — Cash Flow-to-Debt Ratio
Teva Pharmaceutical Industries Ltd (TEVA) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of ILA313.17 Million could theoretically repay 0% of its total liabilities (ILA32.11 Billion) in one year. See how much free cash does Teva Pharmaceutical Industries Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Teva Pharmaceutical Industries Ltd Cash Flow-to-Debt Ratio (1991–2025)
Historical debt coverage capacity for Teva Pharmaceutical Industries Ltd across 35 annual periods. Also explore net asset momentum of Teva Pharmaceutical Industries Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year debt coverage analysis for Teva Pharmaceutical Industries Ltd. For market capitalisation and broader financial context, see Teva Pharmaceutical Industries Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | ILA3.10 Billion | ILA32.84 Billion | ▲ +154.3% |
| 2024 | 0.04x | ILA1.25 Billion | ILA33.61 Billion | ▼ -4.1% |
| 2023 | 0.04x | ILA1.37 Billion | ILA35.35 Billion | ▼ -14.1% |
| 2022 | 0.05x | ILA1.59 Billion | ILA35.31 Billion | ▲ +105.5% |
| 2021 | 0.02x | ILA798.00 Million | ILA36.42 Billion | ▼ -28.7% |
| 2020 | 0.03x | ILA1.22 Billion | ILA39.58 Billion | ▲ +142.2% |
| 2019 | 0.01x | ILA538.00 Million | ILA42.41 Billion | ▼ -76.7% |
| 2018 | 0.05x | ILA2.45 Billion | ILA44.89 Billion | ▼ -19.4% |
| 2017 | 0.07x | ILA3.51 Billion | ILA51.87 Billion | ▼ -25.1% |
| 2016 | 0.09x | ILA5.22 Billion | ILA57.90 Billion | ▼ -60.4% |
| 2015 | 0.23x | ILA5.54 Billion | ILA24.33 Billion | ▲ +2.5% |
| 2014 | 0.22x | ILA5.13 Billion | ILA23.07 Billion | ▲ +70.8% |
| 2013 | 0.13x | ILA3.24 Billion | ILA24.87 Billion | ▼ -21.0% |
| 2012 | 0.16x | ILA4.57 Billion | ILA27.74 Billion | ▲ +10.8% |
| 2011 | 0.15x | ILA4.13 Billion | ILA27.80 Billion | ▼ -38.7% |
| 2010 | 0.24x | ILA4.14 Billion | ILA17.05 Billion | ▲ +4.6% |
| 2009 | 0.23x | ILA3.37 Billion | ILA14.55 Billion | ▲ +18.7% |
| 2008 | 0.20x | ILA3.23 Billion | ILA16.54 Billion | ▲ +4.0% |
| 2007 | 0.19x | ILA1.81 Billion | ILA9.65 Billion | ▼ -15.2% |
| 2006 | 0.22x | ILA2.06 Billion | ILA9.29 Billion | ▼ -29.9% |
| 2005 | 0.32x | ILA1.37 Billion | ILA4.34 Billion | ▲ +7.1% |
| 2004 | 0.30x | ILA1.25 Billion | ILA4.23 Billion | ▲ +23.4% |
| 2003 | 0.24x | ILA626.60 Million | ILA2.62 Billion | ▲ +88.8% |
| 2002 | 0.13x | ILA353.70 Million | ILA2.79 Billion | ▼ -3.7% |
| 2001 | 0.13x | ILA273.15 Million | ILA2.08 Billion | ▲ +35.2% |
| 2000 | 0.10x | ILA165.63 Million | ILA1.70 Billion | ▼ -38.5% |
| 1999 | 0.16x | ILA153.61 Million | ILA971.72 Million | ▲ +74.8% |
| 1998 | 0.09x | ILA70.20 Million | ILA776.40 Million | ▼ -73.1% |
| 1997 | 0.34x | ILA193.60 Million | ILA575.60 Million | ▲ +3593.0% |
| 1996 | -0.01x | ILA-6.80 Million | ILA706.20 Million | ▼ -104.2% |
| 1995 | 0.23x | ILA105.40 Million | ILA463.70 Million | ▲ +98.5% |
| 1994 | 0.11x | ILA38.20 Million | ILA333.60 Million | ▼ -10.4% |
| 1993 | 0.13x | ILA37.70 Million | ILA295.00 Million | ▲ +0.6% |
| 1992 | 0.13x | ILA28.20 Million | ILA221.90 Million | ▲ +170.5% |
| 1991 | 0.05x | ILA9.10 Million | ILA193.70 Million | — |